US Stock Insider Trading | Revvity disclosed 9 insider transactions on February 19

K-LinePoet · 2026-02-23T01:53:35+00:00

Revvity disclosed internal trading activities of executives and directors on February 19, 2026, including Director Singh Prahlad R., who recently sold a large amount of company stock multiple times, totaling over $2 million. Revvity is a company focused on health science solutions.

K-LinePoet

2026-02-23 01:53:35

Abstract generation in progress

On February 19, 2026, Revvity (RVTY) disclosed nine insider trading transactions. Director Singh Prahlad R. sold 6,901 shares on February 17, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 19, 2026	Executive	Vohra Tajinder S	February 17, 2026	Sell	566	96.03	$54,400
February 19, 2026	Director	Singh Prahlad R.	February 17, 2026	Sell	6,901	96.03	$662,700
February 19, 2026	Executive	Krakowiak Maxwell	February 17, 2026	Sell	2,359	96.03	$226,500
February 19, 2026	Executive	Victor Miriame	February 17, 2026	Sell	1,031	96.03	$99,000
February 19, 2026	Executive	Gonzales Anita	February 17, 2026	Sell	237	96.03	$22,800
February 19, 2026	Executive	Goldberg Joel S	February 17, 2026	Sell	1,733	96.03	$166,400
February 6, 2026	Director	Singh Prahlad R.	February 5, 2026	Sell	7,885	100.63	$793,500
February 6, 2026	Director	Singh Prahlad R.	February 5, 2026	Sell	12,200	99.55	$1,213,100
February 6, 2026	Director	Singh Prahlad R.	February 4, 2026	Sell	3,421	101.13	$346,000
February 6, 2026	Director	Singh Prahlad R.	February 5, 2026	Sell	1,068	102.52	$109,500

[Company Profile]

Revvity, Inc. was founded in Massachusetts in 1947. The company is a leading provider of life sciences solutions, technology, expertise, and services, offering a complete workflow from discovery to development, diagnosis to cure. Revvity is transforming healthcare possibilities with a focus on multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes